Emerging evidence from combination therapy reinforces the role of β-blockers in resistant hypertension
European Journal of Internal Medicine · 2026-08 · 150 · 106922
DOI: 10.1016/j.ejim.2026.106922 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Internal Medicine, 2026-08. Verfasst von Stefano Masi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, University of Pisa, Italy. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Clinical and Experimental Medicine, University of Pisa, Italy.
- Department of Medical and Surgical Sciences-University of Bologna, Italy. Electronic address: claudio.borghi@unibo.it.
Zitieren
APA
Masi, S., & Borghi, C. (2026). Emerging evidence from combination therapy reinforces the role of β-blockers in resistant hypertension. European Journal of Internal Medicine, 150, 106922. https://doi.org/10.1016/j.ejim.2026.106922
Vancouver
Masi S, Borghi C. Emerging evidence from combination therapy reinforces the role of β-blockers in resistant hypertension. European Journal of Internal Medicine. 2026;150:106922. doi:10.1016/j.ejim.2026.106922
BibTeX
@article{Masi2026,
author = {Masi, Stefano and Borghi, Claudio},
title = {Emerging evidence from combination therapy reinforces the role of β-blockers in resistant hypertension},
journal = {European Journal of Internal Medicine},
year = {2026},
volume = {150},
pages = {106922},
doi = {10.1016/j.ejim.2026.106922}
}
EUVIMED